Form D Explorer

Form C-AR — AlphaRose Therapeutics Inc

0001665160-25-000789 · filed 2025-04-29

Offering

Target: —
Maximum: —
Security type: —
Price per security: —
Deadline: —
Oversubscription: —

Issuer

Name: AlphaRose Therapeutics Inc
CIK: 2051498
Entity: Corporation
Jurisdiction: DE
Address: 1401 LAVACA STREET, #851
AUSTIN, TX 78701
Phone: —

Most recent fiscal year financials

Total assets

$614,498

Cash

—

Short-term debt

$81,098

Long-term debt

$1,070,000

Revenues

—

COGS

—

Taxes paid

—

Net income

$-625,253

View original on SEC EDGAR.